A narrative review synthesizing published molecular datasets on hepatitis B virus subgenotype D1 reveals that amino-acid substitutions within the multifunctional regulatory protein HBx follow distinct structural and clinical patterns across acute infection, chronic hepatitis, and hepatocellular carcinoma. Genotype D represents one of the most widely distributed lineages of hepatitis B virus worldwide, predominating across the Middle East, North Africa, and parts of Southern Europe, with subgenotype D1 serving as the primary circulating variant in countries such as Iran. Despite this widespread prevalence, the authors emphasize that the vast majority of historical mechanistic insights into HBx biology have been derived from genotypes B and C, which dominate research cohorts in East Asia and Western nations. By gathering previously published phase-specific studies, in silico structural models, protein–protein interaction networks, and phylogenetic reconstructions, the review establishes a conceptual framework linking viral genetic variability to structural plasticity across distinct stages of liver disease without presenting new clinical samples or asserting unverified causal mechanisms.
Hepatitis B virus remains a massive global health burden, affecting more than 296 million chronically infected individuals and causing approximately 900,000 annual deaths primarily attributed to cirrhosis and hepatocellular carcinoma. Within the viral genome, the HBx gene encodes a pleiotropic regulatory protein that does not function as an enzyme or a classical oncogene but instead modulates an array of host cellular processes. Prior investigations highlighted by the review show that HBx participates in viral replication, host transcriptional regulation, epigenetic modulation, apoptotic pathways, and mitochondrial signaling. Because HBx interacts extensively with host machinery involved in DNA repair, chromatin remodeling, and proteostatic turnover, structural modifications within its coding sequence can alter interaction dynamics, viral persistence, and the broader clinical course of infection. Genotype D infections in particular exhibit distinctive clinical and virological profiles, including lower rates of hepatitis B e-antigen positivity, distinct seroconversion patterns, and characteristic mutation clusters within the basal core promoter and HBx regions.
The linear architecture of the 154-amino-acid HBx protein encompasses three major functional regions: an intrinsically disordered N-terminal regulatory domain spanning residues 1 to 50, a central transactivation region spanning residues 51 to 140, and a short C-terminal tail covering residues 141 to 154. Within the central transactivation domain reside several functionally critical motifs, including a mitochondrial targeting sequence between amino acids 55 and 72, an H-box and DNA damage-binding protein 1 interaction motif between residues 88 and 100, and a BH3-like region between positions 110 and 135. Comparative mapping of published sequences demonstrates that mutational occurrences are non-randomly distributed, clustering predominantly within structurally flexible and interaction-rich domains. Acute infection variants localize primarily within or adjacent to the N-terminal regulatory segment, while chronic hepatitis B sequences frequently display recurrent substitutions within the transactivation domain, and hepatocellular carcinoma isolates exhibit extensive alterations extending through the distal transactivation region and the C-terminal tail.
In acute hepatitis B infection, the observed sequence variability remains relatively restricted, reflecting the largely conserved nature of HBx during early host–virus encounters. Representative variants detected in early disease stages, such as the glycine-to-lysine substitution at position 50 (G50K) near the regulatory–transactivation boundary, map to regions of intrinsic structural flexibility. Computational three-dimensional modeling indicates that acute-phase variants preserve the overall topological configuration of the protein, producing only minor side-chain conformational adjustments distal to the core alpha-helical segments. The review notes that these early substitutions, although lacking direct experimental validation in genotype D1 laboratory assays, likely reflect transient host immune-mediated selective pressures or rapid conformational adaptations during initial replication rather than permanent drivers of cellular transformation.
As hepatitis B infection transitions into chronicity, the mutational spectrum broadens substantially, prominently featuring recurrent replacements of glycine residues, including G37A, G43D, and G73V, alongside additional substitutions at residues such as 101 and 131. These chronic-phase alterations map within or adjacent to critical interaction modules, including the mitochondrial targeting domain and the H-box motif that interfaces with cellular DNA damage-binding protein 1. Three-dimensional protein modeling conducted using SWISS-MODEL and visualized through UCSF Chimera demonstrates that these glycine substitutions occur in close proximity to the predicted C-terminal alpha-helix. Because glycine residues possess unique physicochemical properties that provide conformational flexibility to polypeptide chains, their alteration within this helix is hypothesized to influence local dynamic adaptability, structural stability, and interaction strength with host regulatory factors without causing complete protein unfolding.
In sequences recovered from patients with hepatocellular carcinoma, the mutational profile shifts markedly from point substitutions toward structural disruption, domain-level alterations, and C-terminal truncations. Malignant tissues frequently harbor truncated HBx variants, such as the premature stop codon introduced at glycine 135 (G135*), which eliminates the distal C-terminal tail and truncates portions of the BH3-like segment. Point mutations such as T81P, S101P, and V131I also appear recurrently in tumor-associated cohorts. Literature evaluated in the review indicates that C-terminal truncations frequently impair normal proteasomal degradation pathways, lead to protein aggregate formation, and prolong intracellular HBx stability. This prolonged steady-state accumulation is thought to sustain dysregulated signaling cascades, including nuclear factor kappa B activation, oxidative stress responses, mitochondrial impairment, and altered transcriptional control, although the authors stress that available data demonstrate associations rather than definitive linear causation.
To contextualize these mutational patterns within broader host cellular networks, the review incorporates graph-based protein–protein interaction network analysis reconstructed from the STRING database. The resulting interactome demonstrates that HBx functions as an interconnected signaling hub interacting with vital cellular regulators governing apoptosis, including BAX and CFLAR; proinflammatory cytokine signaling, such as tumor necrosis factor and interleukin 6; cellular survival, including BIRC5; and transcriptional control and chromatin organization, through p53 and GTF2B. Confidence-weighted interaction edges emphasize that structural alterations within the transactivation domain or loss of the C-terminal segment may reconfigure binding affinities across these discrete protein clusters. Modulating these host pathways provides a plausible mechanistic scaffold explaining how viral variants could facilitate immune evasion and sustain microenvironmental conditions conducive to oncogenesis.
Evolutionary relationships among the viral isolates were examined through maximum likelihood phylogenetic reconstruction using MEGA X software and the Tamura–Nei substitution model with 1000 bootstrap replicates. The analyzed HBx nucleotide sequences from Iranian cohorts across acute, chronic, and malignant liver disease clustered tightly within established genotype D1 reference sequences, including U95551.1, AB033559, and AB033560, with internal nodes supported by bootstrap values exceeding 70 percent. These sequences formed a well-defined monophyletic lineage strictly segregated from genotypes D2, D5, A, and C, confirming regional genetic conservation and ruling out inter-genotype recombination. Moderate branch lengths separating acute, chronic, and carcinoma specimens indicated ongoing intra-lineage microevolution within the conserved D1 backbone, validating the necessity of using genotype D1-specific structural and evolutionary reference frameworks rather than extrapolating findings from divergent genotypes.
Synthesizing these structural, computational, and phylogenetic observations, the authors articulate a unifying, hypothesis-generating model centered on glycine plasticity as a facilitator of HBx functional diversification. Under this model, the intrinsic flexibility provided by glycine residues allows HBx to tolerate localized amino-acid replacements under host selective pressures during persistent infection. Over extended periods of chronic inflammation, recurrent glycine substitutions within flexible hinge regions may alter local folding dynamics, modify protein turnover, and increase susceptibility to subsequent domain-disrupting mutations and C-terminal truncation events observed in advanced disease. The authors explicitly state that this model represents an evolutionary and conceptual perspective rather than a deterministic clinical prediction, emphasizing that individual mutations should not be viewed as standalone oncogenic switches.
The review delineates several substantial limitations inherent to current literature on genotype D1 HBx, which prevent immediate clinical translation. Foremost is the absence of direct experimental functional validation, as the proposed effects on conformational stability and host-protein interactions rest largely on in silico modeling and database inferences rather than site-directed mutagenesis, cellular reporter assays, or animal models. Furthermore, existing published datasets suffer from small cohort sizes, inconsistent reporting of antiviral treatment exposure, heterogeneous sequencing thresholds, and a lack of longitudinal clinical outcomes such as fibrosis progression, viral load dynamics, and survival rates. In addition, experimental three-dimensional crystal structures of full-length HBx remain unavailable, and the potential biological consequences of overlapping open reading frames—where HBx nucleotide mutations concurrently alter the viral polymerase or regulatory elements—were not evaluated. Consequently, the authors conclude that multicenter, genotype-stratified studies and standardized functional evaluations will be essential to establish whether specific HBx mutational profiles can serve as reliable prognostic biomarkers or inform future antiviral strategies.
Subject of Research: Molecular evolution and structural mutational patterns of HBx in genotype D1 hepatitis B virus across clinical disease stages
Article Title: Evolutionary and functional landscape of HBx mutations in genotype D1 HBV: comparative insights from acute infection, chronic hepatitis, and HCC
Article References: Jalali, K. M., Alkhawaja, A. S., Xursandov, I., Gayratjon, E., Axmedova, F., Zarina, T., Vazira, E., & Rustam, T. (2026). Evolutionary and functional landscape of HBx mutations in genotype D1 HBV: comparative insights from acute infection, chronic hepatitis, and HCC. Infectious Agents and Cancer, 21(1), Article 78. https://doi.org/10.1186/s13027-026-00789-w
Image Credits: AI Generated
DOI: 10.1186/s13027-026-00789-w
Keywords: hepatitis B virus, HBx protein, genotype D1, hepatocellular carcinoma, chronic hepatitis B, viral mutations, glycine plasticity, C-terminal truncation, protein-protein interactions, transactivation domain, phylogenetic analysis, Middle East viral genomics, structural modeling, molecular pathogenesis, viral persistence, host-virus interactions, DDB1 binding motif
News Source: Kristina Jarvis. (November 20, 2026). Genotype D1 Hepatitis B Virus Protein Mutations Follow Phase-Dependent Structural Shifts. Scienmag.



